SEC Form 4 · accession 0001177648-19-000030
ENANTA PHARMACEUTICALS INC · ENTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nathaniel S. Gardiner
Officer — Sr. VP & General Counsel
Period of report
Mar 6, 2019
Accepted (ET)
Mar 7, 2019 · 4:20 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001177648
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 6, 2019 | M | 1,724 | $34.70 | A | 25,702 | D | |
| Common Stock | Mar 6, 2019 | M | 795 | $31.42 | A | 26,497 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $34.70 | Mar 6, 2019 | M | 1,724 | D | — | May 9, 2024 | Common Stock | 1,724 | 70,976 | D |
| Stock Option (right to buy)F2 | $31.42 | Mar 6, 2019 | M | 795 | D | — | Nov 20, 2025 | Common Stock | 795 | 24,705 | D |
Explanation of responses
- F1100% of the shares subject to the option are fully vested and exercisable.
- F2This option to purchase a total of 25,500 shares of common stock became or will become exercisable (subject to the optionholder's continued employment) quarterly in substantially equal installments (any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding quarterly period in which a whole share equivalent is accumulated) over four years from the date of grant (November 20, 2015).